The U.S. aesthetics industry is in the middle of a major shift. A recent Guidepoint Qsight report shows that regenerative skincare sales in aesthetic clinics jumped by about 20% year-over-year in 2025. This isn't just a number; it signals a clear move by both clients and practitioners away from treatments that only cover up problems and toward solutions that help the body repair itself. This growing appetite for advanced aesthetic science is exactly what AXOBIO USA was created to satisfy, bringing clinically formulated regenerative skincare from South Korea—a global hub for aesthetic innovation—to licensed U.S. professionals.

Key  Takeaways

  • The market's 20% growth in regenerative aesthetics is part of a lasting shift in what consumers want: treatments that deliver real, long-term biological improvements.